Changes in serum levels of metalloproteinases and their inhibitors by treatment of chronic hepatitis C with interferon

Digestive Diseases and Sciences

Volumn 41, Issue 5, 1996, Pages 995-1000

  Arai, Masao ^a   Niioka, Maki ^b   Maruyama, Katsuya ^b   Wada, Norihito ^b   Fujimoto, Noboru ^b   Nomiyama, Tetsu ^b   Tanaka, Shoutarou ^b   Okazaki, Isao ^b  

^a TOKAI UNIVERSITY   (Japan)

^b NONE

Author keywords

chronic hepatitis C; interferon; matrix metalloproteinases; tissue inhibitors of metalloproteinases

Indexed keywords

ALPHA INTERFERON; ENDOGENOUS COMPOUND; METALLOPROTEINASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; IMMUNOASSAY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029996342     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02091543     Document Type: Article

References (38)

1. Choo Q-L, Kuo G, Weiner AJ: Isolation of cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:354-362, 1484
2. Kuo G, Choo Q-L, Alter HJ: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364, 1489
3. Wai-Kuo Shih J, Esteban Mur JI, Alter HJ: Non-A, non-B hepatitis: Advances and unfulfilled expectations of the first decade. Prog Liver Dis 8:433-453, 1986
4. Gibo Y, Kiyosawa K, Furuta S: Long-term outcome of non-A, non-B chronic hepatitis in comparison with that of type B chronic hepatitis. In Chronic Hepatitis. YF Liaw (ed), Amsterdam, Elsevier, 1986, pp 221-226
5. Hoofnagle JH, Mullen KD, Jones B, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA: Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report. N Engl J Med 315:1575-1578, 1986
6. Schvarcz R, Weiland O, Wejstal R, Norkarans G, Fryden A, Foberg U: A randomized controlled open study of interferon alpha-2b treatment of chronic non-A, non-B posttransfusion hepatitis: No correlation of outcome to presence of hepatitis C virus antibodies. Scand J Infect Dis 21:617-625, 1989
7. Omata M, Ito Y, Yokosuka O, Imazaki F, Uchiumi K, Takano S, Hosoda K, Ohto M: Histological changes of liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Dig Dis Sci 34:330-337, 1989
8. Nakano Y, Kiyosawa K, Sodeyama T, Tanaka E: Comparative study of clinical, histological, and immunological responses to interferon therapy in type non-A, non-B, and type B chronic hepatitis. Am J Gastroenterol 85:24-29, 1990
9. Causse X, Godinot H, Chevallier M, Chossegros P, Zoulim F, Ouzan D, Heyraud J-P, Fontanges T, Albrecht J, Meschievitz C, Trepo C: Comparison of 1 or 3 MU of interferon alpha-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497-502, 1991
10. Capra F, Casaril M, Gabrielli GB, Tognella P, Rizzi A, Dolci L, Colombari R, Mezzelani P, Corrocher R, De Sandre G: Alpha-interferon in the treatment of chronic viral hepatitis: Effects on fibrogenesis serum markers. J Hepatol 18:112-118, 1993
11. Castilla A, Camps-Bansell J, Civeira M-P, Prieto J: Lymphoblastoid alpha-interferon for chronic hepatitis C: A randomized controlled study. Am J Gastroenterol 88:233-239, 1993
12. Manabe N, Chevallier M, Chossegros P, Causse X, Guerret S, Trepo C, Grimaud J-A: Interferon alpha 2b therapy reduces liver fibrosis in chronic non-A, non-B hepatitis: A quantitative histological evaluation. Hepatology 18:1344-1349, 1993
13. Teran JC, Mullen KD, Hoofnagle JH, McCullough AJ: Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon-alpha. Hepatology 19:849-856, 1994
14. Okazaki I, Maruyama K: Collagenase activity in experimental hepatic fibrosis. Nature 252:49-50, 1974
15. Maruyama K, Feinman L, Okazaki I, Lieber CS: Direct measurement of neutral collagenase activity in homogenates from baboon and human liver. Biochim Biophy Acta 658:124-131, 1981
16. Maruyama K, Feinman L, Fainsilber Z, Nakano M, Okazaki I, Lieber CS: Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis. Life Sci 30:1379-1384, 1982
17. Maruyama K, Okazaki I, Kobayashi T, Suzuki H, Kashiwazaki K, Tsuchiya M: Collagenase production by rabbit liver cells in monolayer culture. J Lab Clin Med 102:543-550, 1983
18. Otani Y, Okazaki I, Arai M, Kameyama K, Wada N, Maruyama K, Yoshino K, Kitajima M, Hosoda Y, Tsuchiya M: Gene expression of interstitial collagenase (matrix metalloproteinase 1) in gastrointestinal tract cancers. J Gastroenterol 29:391-397, 1994
19. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Neil K, Kiernan TW, Wollman J: Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1:431-435, 1981
20. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 219:1-14, 1993
21. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 221:91-103, 1993
22. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 211:59-72, 1992
23. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T: Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127:103-108, 1990
24. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T: A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 220:31-45, 1993
25. Obata K, Iwata K, Ichida T, Inoue K, Matsumoto E, Muragaki Y, Ooshima A: One-step sandwich enzyme immunoassay for human type IV collagen using monoclonal antibodies. Clin Chim Acta 181:293-304, 1989
26. Fujimoto N, Sejima H, Kotani M: One-step sandwich enzyme immunoassay for human laminin using monoclonal antibodies. Clin Chim Acta 191:211-220, 1990
27. Greenberg HB, Follard RB, Lutwick LI: Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 295:517-522, 1976
28. Castilla A, Prieto J, Fausto N: Transforming growth factors beta1 and alpha in chronic liver disease. Effects of interferon alpha therapy. N Engl J Med 324:933-940, 1991
29. Hogemann B, Domschke W: Hepatic fibrosis-Current concept of pathogenesis and therapy. Gastroenterol Jpn 28:570-579, 1993
30. Kovacs EJ: Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today 12:17-23, 1991
31. Edwards DR, Murphy G, Reynolds JJ, Whitham SE, Dochert AJP, Angel P, Heath JK: Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitors. EMBO J 6:1899-1904, 1987
32. Ito A, Sato T, Iga T, Mori Y: Tumor necrosis factor bifunctionally regulates matrix metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) production by human fibroblasts. FEBS Lett 269:93-95, 1990
33. Shimgu M, Nagai Y, Isayama T, Naono T, Nobunaga M, Nagai Y: The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clin Exp Immunol 94:145-149, 1993
34. Jimenez SA, Freundlich B, Rosenbloom J: Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest 74:1112-1116, 1984
35. Czaja MJ, Weiner FR, Takahashi S, Giambrone M-A, van der Meide PH, Schellekens H, Biempica L, Zern MA: Gamma-interferon treatment inhibits collagen deposition in murine schistosomiasis. Hepatology 10:795-800, 1989
36. Varga J, Olsen A, Herhal J, Constantine G, Rosenbloom J, Jimenez SA: Interferon-gamma reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor-beta in normal human fibroblasts. Eur J Clin Invest 20:487-493, 1990
37. Berman B, Duncan MR: Short-term keloid treatment in vivo with human interferon alpha-2b results in a selective and persistent normalization of keloidal fibroblast collagen, glycosaminoglycan, and collagenase production in vitro. J Am Acad Dermatol 21:694-702, 1989
38. Duncan MD, Berman B: Differential regulation of glycosaminoglycan, fibronection, and collagenase production in cultured human dermal fibroblasts by interferon-alpha, -beta, and -gamma. Arch Dermatol Res 281:11-18, 1989